Beyond GOG258 and PORTEC3: A National Cancer Database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer
Purpose: High-risk Endometrial Cancer (EC) treatment decisions have been informed by two large, randomized trials: GOG-258 and PORTEC-3. Directly comparing these studies to determine the optimal treatment strategy remains challenging as neither included all three arms of interest: chemotherapy alone...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2025-06-01
|
| シリーズ: | Gynecologic Oncology Reports |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2352578925000815 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
